Biotechnologies - into life

Found results: 262

Biotechnologies - into life

From the heading "Man of Sciences"

Biotechnologist and plant physiologist from UrFU Alexander Yermoshin debunks myths about the harm of genetically modified vegetables and talks about Christmas trees in test tubes and about which plant can save soils contaminated with heavy metals.

09.10.2015
Biotechnologies - into life

Cancer and "-omics"

Despite the more applied economic nature of the third international forum of Central Bankers-2015, many scientists take part in its work.

18.09.2015
Biotechnologies - into life

Cellular technologies in Ulyanovsk

The Center for Fundamental and Applied Problems of bioecology and Biotechnology of UGPI plans to use the obtained cellular products in clinics for more effective treatment of burns, ulcers, mechanical injuries of the skin.

15.09.2015
Biotechnologies - into life

Unique Russian development will be sold in the USA

The Russian company Semiotic and GlycoTech Corporation (USA) have signed a 5–year agreement on the distribution in North America of a unique Russian development - a research carbohydrate microchip (glycochip) for the quantitative determination of glycan-binding proteins.

27.05.2015
Biotechnologies - into life

Stem cells in a vortex

Koltsovskaya company "Center of Vortex Technologies" received five million rubles from Skolkovo to create a working model of a vortex bioreactor for growing stem cells.

13.05.2015
Biotechnologies - into life

Biotechnological bulletproof vests

Biotechnologists of Perm University have developed a new method for producing nanocellulose. The material is stronger than steel and can be used in various industries – from super-flexible screens to bulletproof vests.

21.04.2015
Biotechnologies - into life

How the medicine is created

Biocad is one of the few full–cycle companies in Russia. This means that innovative medicines are being developed independently here from the molecule to the market.

16.03.2015
Biotechnologies - into life

Neonatal genodiagnostics in St. Petersburg: details

The inclusion of genetic analysis in neonatal screening increases the accuracy of the study, and the use of a new generation sequencing method allows you to simultaneously and quickly check almost any number of mutations.

30.01.2015
Biotechnologies - into life

Center for Neonatal Genodiagnostics in St. Petersburg

In St. Petersburg, for the first time in Russia, genetic testing of severe hereditary diseases in newborns will begin using high-performance genomic analysis technologies.

21.01.2015
Biotechnologies - into life

How to build a bridge from an idea to a pharmacy

Selecta is working on the creation of nanovaccines for the prevention and treatment of serious diseases. An effective, safe vaccine will turn out – the company will earn money. And society will receive a new, useful tool that may save many lives.

15.01.2015
Biotechnologies - into life

Nanolek has opened the first stage of the biopharmaceutical complex

In two years it will be an enterprise where new technologies and products are being developed in one of the most promising segments – biopharmaceuticals. In the near future, the company plans to bring 15 of its own innovative drugs to the market.

24.12.2014
Biotechnologies - into life

In the top ten – the method of early diagnosis of cancer

The project of the SIGMA nanocenter.Novosibirsk" entered the top 50 Russian startups and the top ten biomedical projects of 2014 according to the Russian Startup Rating for the recent diagnosis of cancer.

11.12.2014
Biotechnologies - into life

World-class Russian biomedicine

The PrimeBioMed project is aimed at solving an important and ambitious task – the creation in Russia of a unique biotechnological production of medical devices that is not inferior in quality to the best Western analogues.

04.12.2014
Biotechnologies - into life

The first in Russia and the third in the world

The robotic complex for growing cells in FEFU became the first of its kind in Russia and has only two analogues in the world, which work in leading research centers in the USA and France.

28.11.2014
Biotechnologies - into life

Liver "in vitro" for drug developers

The company Organovo, known for its discoveries in the field of 3D bioprinting, has launched the artificial human liver tissue exVive3D for preclinical testing of new drugs.

27.11.2014
Biotechnologies - into life

We'll go the other way

Big Pharma is in crisis, it is looking for ways to improve the efficiency of promoting medicines from the laboratory to the market. The Russian "New Pharma" has every chance to work ahead of the curve and release a pool of innovative drugs faster than its Western counterparts.

26.11.2014